Hisun Pharmaceutical (002653.SZ): Innovative drug HSK51155 tablet IND application accepted.

Zhixin Finance APP News, Hisun Pharmaceutical (002653.SZ) announced that the company recently received a "Acceptance Notification Letter" issued by the National Medical Products Administration. HSK51155 is an orally administered small molecule non-opioid innovative analgesic drug independently developed by the company with independent intellectual property rights. According to the announcement "Classification and Application Data Requirements for Chemical Drug Registration" issued by the National Medical Products Administration (No. 44 of 2020), this product belongs to Class 1 of chemical drugs.